201 related articles for article (PubMed ID: 1088165)
1. Lymphopenia in Sjögren's syndrome with rheumatoid arthritis: relationship to lymphocytotoxic antibodies, cryoglobulinemia, and impaired mitogen responsiveness.
Utsinger PD; Yount WJ
J Rheumatol; 1976 Dec; 3(4):355-66. PubMed ID: 1088165
[TBL] [Abstract][Full Text] [Related]
2. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.
Utsinger PD
J Rheumatol; 1976 Jun; 3(2):175-85. PubMed ID: 1084929
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
4. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
7. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2.
Fox RI; Theofilopoulos AN; Altman A
J Immunol; 1985 Nov; 135(5):3109-15. PubMed ID: 3876375
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody defined T cell subsets in primary and secondary Sjögren's syndrome.
Fossaluzza V; Rossi P; Tosato F; Pirrone S; Tonutti E; Sala PG
Boll Ist Sieroter Milan; 1986; 65(5):440-2. PubMed ID: 3493793
[TBL] [Abstract][Full Text] [Related]
9. Cryoglobulinemia in primary Sjögren's syndrome: a monoclonal process.
Tzioufas AG; Costello R; Manoussakis MN; Papadopoulos NM; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():111-3. PubMed ID: 3109019
[TBL] [Abstract][Full Text] [Related]
10. [Cryoglobulinemia in rheumatic diseases].
Baranauskaĭte AA; Nasonov EL; Solov'ev SK
Klin Med (Mosk); 1991 Jun; 69(6):23-32. PubMed ID: 1774903
[No Abstract] [Full Text] [Related]
11. Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells.
Horwitz DA; Juul-Nielsen K
Clin Exp Immunol; 1977 Dec; 30(3):370-8. PubMed ID: 304786
[TBL] [Abstract][Full Text] [Related]
12. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
[TBL] [Abstract][Full Text] [Related]
13. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome in systemic lupus erythematosus and rheumatoid arthritis: immune effector cells in salivary glands.
Malmström M; Seppä A; Konttinen YT; Helve T; Reitamo S
Rheumatol Int; 1983; 3(1):1-5. PubMed ID: 6604304
[TBL] [Abstract][Full Text] [Related]
15. Pemphigus foliaceus in a patient with rheumatoid arthritis and Sjögren's syndrome. A case report.
Falk ES
Dermatologica; 1979; 158(5):348-54. PubMed ID: 374144
[TBL] [Abstract][Full Text] [Related]
16. Cold-reactive lymphocytotoxic antibodies in mixed connective tissue disease.
Diaz-Jouanen E; Llorente L; Ramos-Niembro F; Alarcon-Segovia D
J Rheumatol; 1977; 4(1):4-10. PubMed ID: 301941
[TBL] [Abstract][Full Text] [Related]
17. The role of the laboratory in rheumatology. Lymphocytes.
Russell AS; Edelman J
Clin Rheum Dis; 1983 Apr; 9(1):117-34. PubMed ID: 6603321
[No Abstract] [Full Text] [Related]
18. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
19. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM
J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594
[TBL] [Abstract][Full Text] [Related]
20. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
